Clorgiline (INN), orclorgyline (BAN), is amonoamine oxidase inhibitor (MAOI) structurally related topargyline which is described as anantidepressant.[1][2] Specifically, it is anirreversible andselectiveinhibitor ofmonoamine oxidase A (MAO-A).[3] Clorgiline was never marketed,[1] but it has found use inscientific research.[4] It has been found to bind with highaffinity to theσ1 receptor (Ki = 3.2 nM)[3][5] and with very high affinity to theI2 imidazoline receptor (Ki = 40 pM).[6]
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H15Cl2NO |
| Molar mass | 272.17 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Unlikeselegiline, clorgiline does not appear to be amonoaminergic activity enhancer (MAE).[7][8][9][10]
Clorgiline is also amultidrug efflux pump inhibitor.[11] Holmeset al., 2012 reverseazole fungicide resistance using clorgiline, showing promise for its use inmultiple fungicide resistance.[11]
References
edit- ^abElks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 304–.ISBN 978-1-4757-2085-3.
- ^Morton IK, Hall JM (6 December 2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 80–.ISBN 978-94-011-4439-1.
- ^abStone TW (January 1993).Acetylcholine, Sigma Receptors, CCK and Eicosanoids, Neurotoxins. Taylor & Francis. pp. 124–.ISBN 978-0-7484-0063-8.
- ^Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, et al. (1998). "Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (Clorgyline) or MAO-B (Selegiline and pargyline)".MAO — the Mother of all Amine Oxidases. Journal of Neural Transmission. Supplement. Vol. 52. pp. 39–48.doi:10.1007/978-3-7091-6499-0_5.ISBN 978-3-211-83037-6.PMID 9564606.
- ^Yossef I (1994).Sigma Receptors. Academic Press. p. 84.ISBN 978-0-12-376350-1.
- ^Piletz JE, Halaris A, Ernsberger PR (1994)."Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression".Critical Reviews in Neurobiology.9 (1): 29–66 (43).PMID 8828003.
- ^Shimazu S, Miklya I (May 2004). "Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives".Prog Neuropsychopharmacol Biol Psychiatry.28 (3):421–427.doi:10.1016/j.pnpbp.2003.11.016.PMID 15093948.
- ^Knoll J (1983)."Deprenyl (selegiline): the history of its development and pharmacological action".Acta Neurol Scand Suppl.95:57–80.doi:10.1111/j.1600-0404.1983.tb01517.x.PMID 6428148.
- ^Knoll J (May 1992). "The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal view".Pharmacology & Toxicology.70 (5 Pt 1):317–321.doi:10.1111/j.1600-0773.1992.tb00480.x.PMID 1608919.
- ^Yen TT, Dalló J, Knoll J (1982). "The aphrodisiac effect of low doses of (-) deprenyl in male rats".Pol J Pharmacol Pharm.34 (5–6):303–308.PMID 6821215.
- ^ab
- •Prasad R, Banerjee A, Shah AH (February 2017). "Resistance to antifungal therapies".Essays in Biochemistry.61 (1).Portland Press (Biochemical Society):157–166.CiteSeerX 10.1.1.1066.1806.doi:10.1042/ebc20160067.PMID 28258238.S2CID 3414820.
- •Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD (March 2012)."The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates".Antimicrobial Agents and Chemotherapy.56 (3).American Society for Microbiology:1508–1515.doi:10.1128/aac.05706-11.PMC 3294898.PMID 22203607.S2CID 21170509.
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |